Please Wait...

FSH // Follico-Stimulating Hormone

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Follicle-Stimulating Hormone is one of the four glycoprotein hormones. Proteins of this family share a common α subunit and have a specific β subunit. They present structural features of the superfamily of cysteine knot protein (this superfamily contain the TGFβ family, bone morphogenetic proteins, …) (Fan and Hendrickson, 2005; Grossmann et al., 1997; Vitt et al., 2001). FSH is secreted by the pituitary gland and binds its receptor expressed on granulosa cells from ovarian follicles and Sertoli cells of the testis, where activation induce cytodifferentiation, estrogen production and induction of LH receptor. FSH, in association with LH is a central hormone in the regulation of reproduction (Ryan et al., 1988). Injections of recombinant (and urinary) FSH are used in reproductive medicine for ovarian stimulation (van Wely et al., 2011).

Bioclinica Lab employs an automated chemiluminescent assay designed for the measurement of FSH in serum.

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (21 hours ago)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (Yesterday)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (6 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen